For decades, Americans heard the same justification for high drug prices. Pharmaceutical executives insisted those prices were unavoidable. Research costs required them. Innovation depended on them. The United States, as the world's most open market, had to pay more than everyone else.Then Eli Lilly cut the monthly price of one of its fla ... Read more |
No comments:
Post a Comment